CureVac SE
CureVac SE is a registered legal entity registered in Germany under HRB 786475 Stuttgart, and its current status with Handelsregister (Commercial Register) is active. Its registered address on file is Tübingen, Germany. 11 shareholders are on record for CureVac SE, and since every one of them is a company rather than an individual, this particular filing does not on its own establish an ultimate beneficial owner (UBO) — identifying one would mean tracing the ownership of each shareholding company in turn. This profile is sourced directly from Handelsregister (Commercial Register) and was last updated on 25 September 2026.
Registration details
Officers
29
Directors and officers of CureVac SE
10 of the 29 officer records shown for CureVac SE are current appointments, filed with Handelsregister (Commercial Register). The remaining 19 records shown (Alexander Zehnder M.b.a., M.d., Sanofi Pasteur and 17 others) are former appointments that have since been resigned. Management authority at CureVac SE sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control. The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.
Group Structure
Group structure of CureVac SE
CureVac SE sits 1 level below its ultimate parent, BioNTech SE, registered in Germany. 5 subsidiaries are recorded beneath it, across 4 jurisdictions. The full chain up to BioNTech SE is derived by walking shareholder filings across jurisdictions; no link in it is independently corroborated by CureVac SE's own shareholder record. Each of these downward relationships is derived rather than filed: resolved by matching entities across the registry network, not stated directly in a single document.
- CureVac Corporate Services GmbH (Germany)
- CureVac Manufacturing GmbH (Germany)
- Curevac Inc (United States)
- CureVac Netherlands B.V. (Netherlands)
- CureVac Swiss AG (Switzerland)
Data availability
Those 5 subsidiaries span Germany, United States, Netherlands, Switzerland jurisdictions, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear.
BioNTech SE
Germany
Frequently asked questions
Who owns CureVac SE?
11 shareholders are currently on record for CureVac SE, held on the Gesellschafterliste (shareholder list), filed under §40 of the GmbHG. The largest of these is iShares Trust-iShares Core MSCI EAFE ETF, holding 4.3% — the largest recorded stake — followed by iShares Trust-iShares Biotechnology ETF at 4.2%; the remaining 9 shareholders shown hold smaller stakes. Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
Who is CureVac SE's UBO (Ultimate Beneficial Owner)?
Every shareholder recorded for CureVac SE is itself a company rather than a natural person, so no Ultimate Beneficial Owner (UBO) is identified at this level; establishing one would require tracing the ownership of each shareholding company in turn.
How many shareholders does CureVac SE have on record?
11 shareholders are shown on record for CureVac SE.
What is CureVac SE's company registration number?
CureVac SE's registration number is HRB 786475 Stuttgart, filed with Handelsregister (Commercial Register) in Germany. Its current status on the register is active.
Is CureVac SE still an active company?
CureVac SE's status on Handelsregister (Commercial Register) is listed as active.
What is CureVac SE's registered address?
The registered address on file for CureVac SE is Tübingen, Germany.
Who are the officers/directors of CureVac SE?
10 of the 29 officer records shown for CureVac SE are current appointments, filed with Handelsregister (Commercial Register). The remaining 19 records shown (Alexander Zehnder M.b.a., M.d., Sanofi Pasteur and 17 others) are former appointments that have since been resigned. Management authority at CureVac SE sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
Does CureVac SE have a parent company or subsidiaries?
CureVac SE sits 1 level below its ultimate parent, BioNTech SE, registered in Germany. 5 subsidiaries are recorded beneath it, across 4 jurisdictions. Those 5 subsidiaries span Germany, United States, Netherlands, Switzerland jurisdictions, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear.
Can Zavia monitor changes to CureVac SE's ownership over time?
This profile reflects a point-in-time snapshot from Handelsregister (Commercial Register). Zavia's monitoring API can track changes to CureVac SE's registered shareholders, officers, and group structure going forward, flagging updates as they're filed rather than requiring a manual recheck.
Can I access CureVac SE's data through an API?
Yes. Zavia's API connects directly to official government ownership registries across 195 countries and territories, including Germany, so records like CureVac SE's registration, shareholder, UBO, and group-structure data can be queried programmatically instead of viewed one page at a time.
Where does this company information come from, and how current is it?
This record is sourced directly from Handelsregister (Commercial Register) and was last synced on 25 September 2026.